Grifols (GRFS) Total Current Liabilities (2010 - 2025)

Grifols (GRFS) reported Total Current Liabilities of $2.4 billion for Q4 2025, up 2.01% on a YoY basis from $2.3 billion in Q4 2024, and up 2.01% quarter-over-quarter from $2.3 billion in Q4 2024.

Grifols (GRFS) Total Current Liabilities (2010 - 2025) Analysis & Trends

Grifols has reported Total Current Liabilities for 16 years, with the latest figure at $2.4 billion in Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 2.01% year-over-year to $2.4 billion; the trailing twelve-month figure through Dec 2025 stood at $2.4 billion (up 2.01% YoY), and the FY2025 full-year result was $2.4 billion, up 4900.43% from the prior year.
  • Total Current Liabilities for Q4 2025 stood at $2.4 billion, up from $2.3 billion in the prior quarter.
  • The five-year high for Total Current Liabilities was $4.0 billion in Q4 2021, with the low at $2.1 billion in Q4 2022.
  • Historically, Total Current Liabilities has averaged $2.6 billion across 5 years, with a median of $2.4 billion in 2025.
  • Annual changes were most pronounced in 2021 — Total Current Liabilities surged 149.68% — and 2022, when it sank 48.17%.
  • Grifols' Total Current Liabilities stood at $4.0 billion in 2021, then slumped by 48.17% to $2.1 billion in 2022, then climbed by 21.45% to $2.5 billion in 2023, then fell by 7.92% to $2.3 billion in 2024, then gained by 2.01% to $2.4 billion in 2025.
  • The last three Total Current Liabilities figures came in at $2.4 billion (Q4 2025), $2.3 billion (Q4 2024), and $2.5 billion (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -30.24 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 36.63 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 57.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 42.10 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 26.95 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 9.48 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 34.35 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 19.16 Bn
10 Grifols 6.05 Bn 5.09 Bn - 2.35 Bn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.35 Bn
Dec 31, 2024 2.30 Bn
Dec 31, 2023 2.50 Bn
Dec 31, 2022 2.06 Bn
Dec 31, 2021 3.97 Bn
Dec 31, 2020 1.59 Bn
Sep 30, 2020 1.45 Bn
Mar 31, 2020 1.47 Bn
Dec 31, 2019 1.51 Bn
Sep 30, 2019 1.55 Bn
Dec 31, 2018 1.44 Bn
Sep 30, 2018 1.26 Bn
Jun 30, 2018 1.21 Bn
Mar 31, 2018 1.49 Bn
Dec 31, 2017 1.15 Bn
Jun 30, 2017 989.95 Mn
Dec 31, 2016 1.16 Bn
Sep 30, 2016 1.03 Bn
Jun 30, 2016 1.10 Bn
Dec 31, 2015 1.15 Bn